178 related articles for article (PubMed ID: 24913135)
21. Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging.
Kim TH; Jeong CW; Jun HY; Kim YR; Kim JY; Lee YH; Yoon KH
Acad Radiol; 2019 Jun; 26(6):766-774. PubMed ID: 30143402
[TBL] [Abstract][Full Text] [Related]
22. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP
Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
[TBL] [Abstract][Full Text] [Related]
23. Coleus forskohlii Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model.
Suzuki S; Nishijima C; Sato Y; Umegaki K; Murata M; Chiba T
J Nutr Sci Vitaminol (Tokyo); 2020; 66(2):191-199. PubMed ID: 32350181
[TBL] [Abstract][Full Text] [Related]
24. Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.
Kirpich IA; Gobejishvili LN; Bon Homme M; Waigel S; Cave M; Arteel G; Barve SS; McClain CJ; Deaciuc IV
J Nutr Biochem; 2011 Jan; 22(1):38-45. PubMed ID: 20303728
[TBL] [Abstract][Full Text] [Related]
25. Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Li P; Robertson TA; Thorling CA; Zhang Q; Fletcher LM; Crawford DH; Roberts MS
Drug Metab Dispos; 2011 Apr; 39(4):571-9. PubMed ID: 21245286
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
27. Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.
Sa R; Zhang W; Ge J; Wei X; Zhou Y; Landzberg DR; Wang Z; Han X; Chen L; Yin H
J Mol Cell Biol; 2016 Jun; 8(3):195-206. PubMed ID: 26993042
[TBL] [Abstract][Full Text] [Related]
28. Elovl6 promotes nonalcoholic steatohepatitis.
Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
[TBL] [Abstract][Full Text] [Related]
29. Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.
Pettinelli P; Arendt BM; Teterina A; McGilvray I; Comelli EM; Fung SK; Fischer SE; Allard JP
PLoS One; 2018; 13(10):e0205747. PubMed ID: 30379862
[TBL] [Abstract][Full Text] [Related]
30. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
31. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
[TBL] [Abstract][Full Text] [Related]
32. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
Yamasaki Y; Nouso K; Miyahara K; Wada N; Dohi C; Morimoto Y; Kinugasa H; Takeuchi Y; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Amano M; Nishimura S; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):528-34. PubMed ID: 25168691
[TBL] [Abstract][Full Text] [Related]
33. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
Yoneda M; Mawatari H; Fujita K; Iida H; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
J Gastroenterol; 2007 Jul; 42(7):573-82. PubMed ID: 17653654
[TBL] [Abstract][Full Text] [Related]
34. Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease.
Gonzalez M; Sealls W; Jesch ED; Brosnan MJ; Ladunga I; Ding X; Black PN; DiRusso CC
Physiol Genomics; 2011 Feb; 43(3):121-35. PubMed ID: 21098682
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.
Del Ben M; Overi D; Polimeni L; Carpino G; Labbadia G; Baratta F; Pastori D; Noce V; Gaudio E; Angelico F; Mancone C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463024
[TBL] [Abstract][Full Text] [Related]
36. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
He R; Guan C; Zhao X; Yu L; Cui Y
Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
[TBL] [Abstract][Full Text] [Related]
37. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
[TBL] [Abstract][Full Text] [Related]
38. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
39. Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH).
Maruyama H; Kobayashi K; Kiyono S; Chiba T; Kato N; Ohtsuka M; Ito K; Yamaguchi T; Shiina S
Eur Radiol Exp; 2020 Jan; 4(1):3. PubMed ID: 31975290
[TBL] [Abstract][Full Text] [Related]
40. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
